HomeInsightsStock Comparison

Aurobindo Pharma Ltd vs Brawn Biotech Ltd Stock Comparison

Aurobindo Pharma Ltd vs Brawn Biotech Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1109 as of 22 Jul 12:05.
  • The P/E Ratio of Aurobindo Pharma Ltd changed from 8.5 on March 2020 to 20.1 on March 2024 . This represents a CAGR of 18.78% over 5 yearsThe P/E Ratio of Brawn Biotech Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Aurobindo Pharma Ltd changed from ₹ 24202 crore on March 2020 to ₹ 63835 crore on March 2024 . This represents a CAGR of 21.41% over 5 yearsThe Market Cap of Brawn Biotech Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Aurobindo Pharma Ltd for the Mar '25 is ₹ 8516 crore as compare to the Dec '24 revenue of ₹ 8137 crore. This represent the growth of 4.66% The revenue of Brawn Biotech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Aurobindo Pharma Ltd for the Mar '25 is ₹ 1894 crore as compare to the Dec '24 ebitda of ₹ 1736 crore. This represent the growth of 9.08% The ebitda of Brawn Biotech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Aurobindo Pharma Ltd changed from ₹ 569.71 crore to ₹ 902.83 crore over 8 quarters. This represents a CAGR of 25.89% The net profit of Brawn Biotech Ltd changed from ₹ -0.04 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Aurobindo Pharma Ltd changed from 9.37 % on March 2020 to 13.49 % on March 2024 . This represents a CAGR of 7.56% over 5 yearsThe Dividend Payout of Brawn Biotech Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aurobindo Pharma Ltd

  • Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company.
  • Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
  • APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
  • The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
  • APL is running with 24 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

About Brawn Biotech Ltd

  • Brawn Biotech Ltd was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985.
  • Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to Brawn Biotech Limited in November, 2010.
  • Brawn , with its inception barely 38 years back has today evolved into a fully integrated, healthcare group, marking its presence in India and across the globe. The Company possess product registration with major health and govt. institutions throughout India and worldwide.
  • Headed and represented by a team of skilled industry experts with impressive educational backgrounds and broad experience, the Company has spread its wings in expansion in the domestic as well as in the international markets beyond the existing horizon to stand among the leading Indian HealthCare products distribution Companies.

Aurobindo Pharma Ltd News Hub

News

Aurobindo Pharma Ltd drops for fifth straight session

Aurobindo Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 1...

Read more

11 Jul 2025 13:35

News

CuraTeQ Biologics receives European marketing authorization for biosimilar Dazublys'

CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma, has obt...

Read more

02 Jul 2025 18:36

News

Lyfius Pharma re-starts production at its Penicillin-G manufacturing facility

Aurobindo Pharma announced that its wholly owned step-down subsidiary, Lyfius Pharma has r...

Read more

30 Jun 2025 09:29

News

Aurobindo Pharma Ltd spurts 0.22%, up for fifth straight session

Aurobindo Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs ...

Read more

26 Jun 2025 13:00

News

Aurobindo Pharma gets UK MHRA approval for neutropenia treatment drug Dyrupeg

Dyrupeg contains the active substance pegfilgrastim and is a biological medicine. It is a ...

Read more

25 Jun 2025 12:51

News

CuraTeQ Biologics receives UK MHRA approval for biosimilar Dyrupeg'

Aurobindo Pharma announced that CuraTeQ Biologics s.r.o., a wholly owned step-down subsidi...

Read more

24 Jun 2025 19:01

Brawn Biotech Ltd News Hub

News

Brawn Biotech to table results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 26 May 2025....

Read more

17 May 2025 14:36

News

Brawn Biotech to table results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 12 February ...

Read more

05 Feb 2025 12:58

News

Brawn Biotech to conduct board meeting

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

11 Nov 2024 12:21

News

Brawn Biotech to conduct AGM

Brawn Biotech announced that the 39th Annual General Meeting (AGM) of the company will be ...

Read more

05 Sep 2024 15:14

News

Brawn Biotech to discuss results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 August 20...

Read more

12 Aug 2024 14:29

News

Brawn Biotech to discuss results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2024 ...

Read more

28 May 2024 14:18

SWOT Analysis Of Brawn Biotech Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Brawn Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Aurobindo Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aurobindo Pharma Ltd and Brawn Biotech Ltd

Which company has a larger market capitalization, Aurobindo Pharma Ltd or Brawn Biotech Ltd?

Market cap of Aurobindo Pharma Ltd is 66,706 Cr while Market cap of Brawn Biotech Ltd is 5 Cr

What are the key factors driving the stock performance of Aurobindo Pharma Ltd and Brawn Biotech Ltd?

The stock performance of Aurobindo Pharma Ltd and Brawn Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aurobindo Pharma Ltd and Brawn Biotech Ltd?

As of July 22, 2025, the Aurobindo Pharma Ltd stock price is INR ₹1138.45. On the other hand, Brawn Biotech Ltd stock price is INR ₹19.0.

How do dividend payouts of Aurobindo Pharma Ltd and Brawn Biotech Ltd compare?

To compare the dividend payouts of Aurobindo Pharma Ltd and Brawn Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions